Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Corvex, Inc.MOVE · Entity 5811 | Director | July 07, 2026 | July 08, 2026 |
| IN8BIO, INC.INAB · Entity 7941 | Director | May 27, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Corvex, Inc.
Report date July 07, 2026 · Filed July 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,214,513 |
Reported balance
After 2026-07-07 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2026-07-07 · Conversion · Acquired 1,205,282 · Balance 1,214,513 F1: Based on automatic conversion of 1,205.2825 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). F2: The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 45,129 |
Reported balance
Holding disclosure · report date 2026-07-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 45,129 F4: The securities are held by the Malcolm P. Fairbairn and Emily T. Fairbairn Charitable Remainder Unitrust ("Fairbairn Unitrust"). Emily Fairbairn has voting and investment power over the securities held by Fairbairn Unitrust. Ms. Fairbairn disclaims beneficial ownership of the securities held by Fairbairn Unitrust, except to the extent of her and her spouse's pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 4,783 |
Reported balance
Holding disclosure · report date 2026-07-07 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 4,783 F5: The securities are held by Valley High Limited Partnership ("Valley High"). Emily Fairbairn has voting and investment power over the shares held by Valley High. |
| Series C Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectSee footnote | 0 |
Reported balance
After 2026-07-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-07-07 · Conversion · Disposed 1,205.2825 · Balance 0 F6: The Series C Preferred Stock automatically converted into shares of common stock on July 7, 2026 at a conversion ratio of 1 to 1000 shares of common stock. F1: Based on automatic conversion of 1,205.2825 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). F7: The preferred stock is perpetual and therefore has no expiration date F2: The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 228,577 |
Reported balance
Holding disclosure · report date 2026-07-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 228,577 F3: Includes unvested shares of restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Based on automatic conversion of 1,205.2825 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash).
F2: The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein.
F3: Includes unvested shares of restricted stock.
F4: The securities are held by the Malcolm P. Fairbairn and Emily T. Fairbairn Charitable Remainder Unitrust ("Fairbairn Unitrust"). Emily Fairbairn has voting and investment power over the securities held by Fairbairn Unitrust. Ms. Fairbairn disclaims beneficial ownership of the securities held by Fairbairn Unitrust, except to the extent of her and her spouse's pecuniary interest therein.
F5: The securities are held by Valley High Limited Partnership ("Valley High"). Emily Fairbairn has voting and investment power over the shares held by Valley High.
F6: The Series C Preferred Stock automatically converted into shares of common stock on July 7, 2026 at a conversion ratio of 1 to 1000 shares of common stock.
F7: The preferred stock is perpetual and therefore has no expiration date
IN8BIO, INC.
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2026-05-27 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2026-05-27 · Gift · Disposed 724,637 · Balance 0 F1: Represents a bona fide gift for no consideration to a 501(c)(3) charitable foundation. F2: The securities are held by Malcom and Emily Fairbairn 2010 CRUT (the "CRUT"). The Reporting Person is a trustee of the CRUT. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,044 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,044 F3: The securities are held by Valley High Limited Partnership ("Valley High"). Emily Fairbairn's spouse is the sole managing partner of Valley High and has voting and investment power over the shares held by Valley High. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 923 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 923 F4: The securities are held by Emily T. Fairbairn Roth IRA ("Roth IRA"). Emily Fairbairn exercises control over the Roth IRA, and as such, has voting and investment power over the shares held by the Roth IRA. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a bona fide gift for no consideration to a 501(c)(3) charitable foundation.
F2: The securities are held by Malcom and Emily Fairbairn 2010 CRUT (the "CRUT"). The Reporting Person is a trustee of the CRUT.
F3: The securities are held by Valley High Limited Partnership ("Valley High"). Emily Fairbairn's spouse is the sole managing partner of Valley High and has voting and investment power over the shares held by Valley High.
F4: The securities are held by Emily T. Fairbairn Roth IRA ("Roth IRA"). Emily Fairbairn exercises control over the Roth IRA, and as such, has voting and investment power over the shares held by the Roth IRA.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Energous Corp
Report date December 28, 2017 · Filed January 02, 2018
Jointly reported with NINA FAIRBAIRN IRREVOCABLE TRUST SEPTEMBER 30, 2011, Fairbairn Malcolm
Section 16 reporting ended · disclosed 2018-01-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-28 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-12-28 · Other · Disposed 133,333 · Balance 0 F1: On December 28, 2017, the Nina Fairbairn Irrevocable Trust September 30, 2011 (the "Trust") transferred 133,333 shares of common stock of Energous Corporation, a Delaware corporation (the "Issuer"), to a beneficiary of the Trust. After the transfer, the Trust is no longer a 10% owner of the Issuer. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 2,066,918 |
Reported balance
After 2017-12-28 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2017-12-28 · Other · Disposed 133,333 · Balance 2,066,918 F2: Malcolm Fairbairn is a trustee of the Trust. After the above transfer, Malcolm Fairbairn is no longer a 10% owner of the Issuer. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 530,462 |
Reported balance
After 2017-12-28 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2017-12-28 · Other · Disposed 133,333 · Balance 530,462 F3: Emily Fairbairn is a trustee of the Trust. After the above transfer, Emily Fairbairn is no longer a 10% owner of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 28, 2017, the Nina Fairbairn Irrevocable Trust September 30, 2011 (the "Trust") transferred 133,333 shares of common stock of Energous Corporation, a Delaware corporation (the "Issuer"), to a beneficiary of the Trust. After the transfer, the Trust is no longer a 10% owner of the Issuer.
F2: Malcolm Fairbairn is a trustee of the Trust. After the above transfer, Malcolm Fairbairn is no longer a 10% owner of the Issuer.
F3: Emily Fairbairn is a trustee of the Trust. After the above transfer, Emily Fairbairn is no longer a 10% owner of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 07, 2026 Filed Jul 8, 2026 22:30 UTC | Corvex, Inc. MOVE · Entity 5811 | ConversionSeries C Preferred Stock · Derivative | 1,205.2825 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-298811 · ownership.xml · derivative · entry 5 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,205,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Series C Preferred Stock automatically converted into shares of common stock on July 7, 2026 at a conversion ratio of 1 to 1000 shares of common stock. F1 · price: Based on automatic conversion of 1,205.2825 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). F7 · derivative.expiration_date: The preferred stock is perpetual and therefore has no expiration date F2 · ownership.nature: The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. Read SEC document |
| July 07, 2026 Filed Jul 8, 2026 22:30 UTC | Corvex, Inc. MOVE · Entity 5811 | ConversionCommon Stock | 1,205,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-298811 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,214,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Based on automatic conversion of 1,205.2825 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). F2 · ownership.nature: The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. Read SEC document |
| July 01, 2026 Filed Jul 3, 2026 01:58 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantSeries D Preferred Stock · Derivative | 858.5403 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-295228 · ownership.xml · derivative · entry 3 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 858.5403 Underlying: Common Stock · 858,540 shares Expires not disclosed F7 · derivative.exercise_price: The shares of Series D Preferred Stock will convert at a conversion ratio of 1 to 1000 shares of common stock upon the delivery of a conversion notice by the Reporting Person to the Issuer. F4 · kind: On July 1, 2026, the Reporting Person exchanged 858.5403 shares of Series C Preferred Stock for 858.5403 shares of Series D Preferred Stock on a one-for-one basis pursuant to an Exchange Agreement entered into with the Issuer. F5 · derivative.expiration_date: The preferred stock is perpetual and therefore has no expiration date. F6 · ownership.nature: The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. Read SEC document |
| July 01, 2026 Filed Jul 3, 2026 01:58 UTC | Corvex, Inc. MOVE · Entity 5811 | Disposition to issuerSeries C Preferred Stock · Derivative | 858.5403 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-295228 · ownership.xml · derivative · entry 2 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,205.2825 Underlying: Common Stock · 858,540 shares Expires not disclosed F3 · derivative.exercise_price: The shares of Series C Preferred Stock will convert at a conversion ratio of 1 to 1000 shares of common stock on July 7, 2026. F4 · kind: On July 1, 2026, the Reporting Person exchanged 858.5403 shares of Series C Preferred Stock for 858.5403 shares of Series D Preferred Stock on a one-for-one basis pursuant to an Exchange Agreement entered into with the Issuer. F3 · derivative.exercise_date: The shares of Series C Preferred Stock will convert at a conversion ratio of 1 to 1000 shares of common stock on July 7, 2026. F5 · derivative.expiration_date: The preferred stock is perpetual and therefore has no expiration date. F6 · ownership.nature: The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. Read SEC document |
| July 01, 2026 Filed Jul 3, 2026 01:58 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantCommon Stock | 135,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-295228 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,577 F1 · shares: Represents a grant of time-based restricted stock units that vest in three equal annual installments from the grant date. F2 · balance_after: As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:39 UTC | IN8BIO, INC. INAB · Entity 7941 | GiftCommon Stock | 724,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001682638-26-000006 · form4-05292026_090552.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Represents a bona fide gift for no consideration to a 501(c)(3) charitable foundation. F2 · ownership.nature: The securities are held by Malcom and Emily Fairbairn 2010 CRUT (the "CRUT"). The Reporting Person is a trustee of the CRUT. Read SEC document |
| May 09, 2026 Filed May 12, 2026 20:30 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 22,000 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001682638-26-000004 · form4-05122026_040510.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2036-05-09 F1 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 9, 2026; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 21:24 UTC | Corvex, Inc. MOVE · Entity 5811 | ConversionSeries B Preferred Stock · Derivative | 9.2319 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-138246 · ownership.xml · derivative · entry 5 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,231 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Series B Preferred Stock automatically converts into shares of common stock on March 31, 2026 at a conversion ratio of 1 to 1000 shares of common stock. F1 · price: Based on automatic conversion of 9.2319 shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). F6 · derivative.expiration_date: The preferred stock is perpetual and therefore has no expiration date Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 21:24 UTC | Corvex, Inc. MOVE · Entity 5811 | ConversionCommon Stock | 9,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-138246 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 9,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Based on automatic conversion of 9.2319 shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). F2 · ownership.nature: The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. Read SEC document |
| March 19, 2026 Filed Mar 19, 2026 21:07 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantSeries C Preferred Stock · Derivative | 2,063.8228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-116174 · ownership.xml · derivative · entry 3 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,063.8228 Underlying: Common Stock · 2,063,823 shares Expires not disclosed F5 · derivative.exercise_price: The shares of Series C Preferred Stock will convert at a conversion ratio of 1 to 1000 shares of common stock upon approval of the Issuer's stockholders for such conversion pursuant to Nasdaq listing rules. F3 · shares: Represents shares of preferred stock received in exchange for the Reporting Person's equity securities in Corvex, Inc. pursuant to the terms of the Amended and Restated Agreement and Plan of Merger, dated March 19, 2026, by and among the Issuer, Thor Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Issuer, and Corvex, Inc. F5 · derivative.exercise_date: The shares of Series C Preferred Stock will convert at a conversion ratio of 1 to 1000 shares of common stock upon approval of the Issuer's stockholders for such conversion pursuant to Nasdaq listing rules. F4 · derivative.expiration_date: The preferred stock is perpetual and therefore has no expiration date Read SEC document |
| March 19, 2026 Filed Mar 19, 2026 21:07 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantSeries B Preferred Stock · Derivative | 9.2319 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-116174 · ownership.xml · derivative · entry 2 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.2319 Underlying: Common Stock · 92,319 shares Expires not disclosed F2 · derivative.exercise_price: The Series B Preferred Stock automatically converts into shares of the Issuer's common stock on March 31, 2026 at a conversion ratio of 1 to 1000 shares of common stock. F3 · shares: Represents shares of preferred stock received in exchange for the Reporting Person's equity securities in Corvex, Inc. pursuant to the terms of the Amended and Restated Agreement and Plan of Merger, dated March 19, 2026, by and among the Issuer, Thor Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Issuer, and Corvex, Inc. F4 · derivative.expiration_date: The preferred stock is perpetual and therefore has no expiration date Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 21:07 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantStock option (right to buy) · Derivative | 200,000 | $0.00 Strike: $15.09 | $0.00 |
DisclosureSEC source: 0001193125-26-116174 · ownership.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2036-03-18 F1 · derivative.exercise_date: This option award vests in three equal annual installments on the anniversary of the grant date. This option award will become exerciseable upon shareholder approval of such award. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 22:01 UTC | Corvex, Inc. MOVE · Entity 5811 | Exercise / conversionStock Options (Right to Buy) · Derivative | 55,250 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001193125-26-111335 · ownership.xml · derivative · entry 4 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,250 shares Expires 2026-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 22:01 UTC | Corvex, Inc. MOVE · Entity 5811 | Exercise / conversionCommon Stock | 55,250 | $1.25 | $69,062.50 |
DisclosureSEC source: 0001193125-26-111335 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 22:55 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantCommon Stock | 5,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-010719 · ownership.xml · nonDerivative · entry 2 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,119 F2 · shares: The reported transaction involved the reporting person's receipt of a grant of 5,959 RSUs under the Company's Omnibus Incentive Plan for the period January 1, 2026 to June 30, 2026. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 22:55 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantCommon Stock | 4,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-010719 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,160 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 4,470 restricted stock units ("RSUs") under the Company's Omnibus Incentive Plan in lieu of cash directors' fees for the period January 1, 2026 to June 30, 2026. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 23:20 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantCommon Stock | 724,637 | $1.38 | $999,999.06 |
DisclosureSEC source: 0001682638-25-000004 · form4-12232025_061201.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 724,637 F1 · ownership.nature: The securities are held by Malcom and Emily Fairbairn 2010 CRUT (the "CRUT"). The Reporting Person is a trustee of the CRUT. Read SEC document |
| November 03, 2025 Filed Nov 10, 2025 22:58 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantStock option (right to buy) · Derivative | 55,250 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001193125-25-274682 · ownership.xml · derivative · entry 2 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,250 Underlying: Common Stock · 55,250 shares Expires 2025-12-31 F2 · derivative.exercise_date: This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option will become exerciseable upon shareholder approval of the Plan Amendment. Read SEC document |
| November 03, 2025 Filed Nov 10, 2025 22:58 UTC | Corvex, Inc. MOVE · Entity 5811 | Disposition to issuerCommon Stock | 12,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-274682 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,690 F1 · shares: The reported transaction involved the reporting person's forfeiture of previously awarded restricted stock units ("RSUs") under the Company's Omnibus Inctive Plan (the "Omnibus Incentive Plan") in lieu of directors' fees in exchange for the grant of stock options. Read SEC document |
| October 03, 2025 Filed Oct 8, 2025 21:00 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantCommon Stock | 31,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-234633 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,315 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 31,028 restricted stock units ("RSUs") under the Company's Omnibus Incentive Plan in lieu of directors' fees for the period October 1, 2025 to December 31, 2025. The total reported in Column 5 consists solely of RSUs. Read SEC document |
| July 03, 2025 Filed Jul 3, 2025 20:30 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantCommon Stock | 27,985 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-093916 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,287 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 27,985 restricted stock units ("RSUs") under the Company's Omnibus Incentive Plan in lieu of directors' fees for the period July 1, 2025 to September 30, 2025. The total reported in Column 5 includes 93,392 RSUs and 26,895 shares of common stock. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:30 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantCommon Stock | 65,407 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-070431 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,302 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 65,407 restricted stock units ("RSUs") under the Company's Omnibus Incentive Plan in lieu of directors' fees for the period October 1, 2024 to June 30, 2025. The total reported in Column 5 includes the 65,407 newly awarded RSUs and 26,895 shares of common stock. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:15 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 63,150 | $0.00 Strike: $0.17 | $0.00 |
DisclosureSEC source: 0001415889-25-012652 · form4-05122025_040514.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,150 Underlying: Common Stock · 63,150 shares Expires 2035-05-08 F1 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 8, 2025; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:29 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantStock Options (Right to Buy) · Derivative | 10,333 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0000950170-25-002170 · ownership.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,333 Underlying: Common Stock · 10,333 shares Expires 2035-01-02 F1 · derivative.exercise_date: The option vests in full on the one-year anniversary of the grant date. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 21:15 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 31,559 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-24-030063 · form4-12232024_041216.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,559 Underlying: Common Stock · 31,559 shares Expires 2034-12-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date. Read SEC document |
| October 09, 2024 Filed Oct 11, 2024 20:30 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantStock option (right to buy) · Derivative | 130,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0000950170-24-114344 · ownership.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2034-10-09 F1 · derivative.exercise_date: The option award vests in full on January 2, 2025. Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 20:15 UTC | IN8BIO, INC. INAB · Entity 7941 | PurchasePre-Funded Warrants (right to buy) · Derivative | 3,038,743 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001415889-24-024872 · form4-10082024_041012.xml · derivative · entry 2 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,038,743 Underlying: Common Stock · 3,038,743 shares Expires not disclosed F2 · price: The reported securities are included within 3,038,743 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share Pre-funded warrant and one Series C warrant each representing the right to purchase 3,038,743 shares of common stock. F4 · derivative.exercise_date: The Pre-funded warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise. F4 · derivative.expiration_date: The Pre-funded warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise. F3 · ownership.nature: The securities are held by the Malcolm and Emily Charitable Remainder Unitrust 2010 (the "Trust"). The Reporting Person is the trustee of the Trust. Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 20:15 UTC | IN8BIO, INC. INAB · Entity 7941 | PurchaseSeries C Warrants (right to buy) · Derivative | 3,038,743 | Not disclosed Strike: $0.27 | Not disclosed |
DisclosureSEC source: 0001415889-24-024872 · form4-10082024_041012.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,038,743 Underlying: Common Stock · 3,038,743 shares Expires 2027-10-04 F2 · price: The reported securities are included within 3,038,743 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share Pre-funded warrant and one Series C warrant each representing the right to purchase 3,038,743 shares of common stock. F1 · derivative.exercise_date: Fully vested and exercisable. F3 · ownership.nature: The securities are held by the Malcolm and Emily Charitable Remainder Unitrust 2010 (the "Trust"). The Reporting Person is the trustee of the Trust. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 21:00 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 33,650 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001415889-24-016967 · form4-06142024_050610.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,650 Underlying: Common Stock · 33,650 shares Expires 2034-06-12 F1 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 12, 2024; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 21:30 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseWarrant to Purchase Common Stock · Derivative | 4,690,000 | Not disclosed Strike: $0.41 | Not disclosed |
DisclosureSEC source: 0000950170-24-041911 · ownership.xml · derivative · entry 4 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 4,690,000 Underlying: Common Stock · 4,690,000 shares Expires 2029-04-04 F1 · price: On April 2, 2024, the reporting person purchased 4,690,000 units (each, a "Unit") from the Company in a private placement. Each Unit consists of one share of Common Stock and one warrant (a "Warrant") to purchase one share of Common Stock. The price per Unit was $0.533, which amount includes $0.125 per Warrant underlying each Unit. F2 · ownership.nature: The securities are held by the Malcolm P. Fairbairn and Emily T. Fairbairn Charitable Remainder Unitrust ("Fairbairn Unitrust"). Emily Fairbairn has voting and investment power over the securities held by Fairbairn Unitrust. Ms. Fairbairn disclaims beneficial ownership of the securities held by Fairbairn Unitrust, except to the extent of her and her spouse's pecuniary interest therein. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 21:30 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseCommon Stock | 4,690,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-041911 · ownership.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 4,985,000 F1 · price: On April 2, 2024, the reporting person purchased 4,690,000 units (each, a "Unit") from the Company in a private placement. Each Unit consists of one share of Common Stock and one warrant (a "Warrant") to purchase one share of Common Stock. The price per Unit was $0.533, which amount includes $0.125 per Warrant underlying each Unit. F2 · ownership.nature: The securities are held by the Malcolm P. Fairbairn and Emily T. Fairbairn Charitable Remainder Unitrust ("Fairbairn Unitrust"). Emily Fairbairn has voting and investment power over the securities held by Fairbairn Unitrust. Ms. Fairbairn disclaims beneficial ownership of the securities held by Fairbairn Unitrust, except to the extent of her and her spouse's pecuniary interest therein. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:30 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0001209191-24-000791 · doc4.xml · derivative · entry 2 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-02 F2 · derivative.exercise_date: The option award vests in full on January 2, 2025. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 21:11 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseCommon Stock | 295,000 | $0.85 | $250,750.00 |
DisclosureSEC source: 0001209191-23-055331 · doc4.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 295,000 F1 · price: Reporting Person purchased 295,000 shares of Common Stock in the Issuer's public offering at a purchase price of $0.85 per share. F2 · ownership.nature: The securities are held by the Malcolm P. Fairbairn and Emily T. Fairbairn Charitable Remainder Unitrust ("Fairbairn Unitrust"). Emily Fairbairn has voting and investment power over the shares held by Fairbairn Unitrust. Read SEC document |
| November 08, 2023 Filed Jan 4, 2024 21:30 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantStock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.97 | $0.00 |
DisclosureSEC source: 0001209191-24-000791 · doc4.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2033-11-08 F1 · derivative.exercise_date: The option award vests in full on November 8, 2024. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 20:41 UTC | IN8BIO, INC. INAB · Entity 7941 | OtherCommon Stock | 4,111,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044002 · doc4.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: These securities are held by Transcend Partners Opportunity Fund I LLC ("Transcend"). Effective July 28, 2023, Transcend appointed new managing members and adopted a policy pursuant to which voting and dispositive decisions with respect to the Issuer's securities require the approval of at least two of Transcend's managers, Grant Fairbairn, Nina Fairbairn and Scott Kintz. Under the so-called "rule of three," if voting and dispositive decisions regarding an entity's securities are made by two or more individuals, and a voting and dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity's securities. Based upon the foregoing analysis, neither an individual manager of Transcend nor the Reporting Person exercises voting or dispositive control over any of the Issuer's securities, even those in which such person may hold a pecuniary interest. F1 · ownership.nature: These securities are held by Transcend Partners Opportunity Fund I LLC ("Transcend"). Effective July 28, 2023, Transcend appointed new managing members and adopted a policy pursuant to which voting and dispositive decisions with respect to the Issuer's securities require the approval of at least two of Transcend's managers, Grant Fairbairn, Nina Fairbairn and Scott Kintz. Under the so-called "rule of three," if voting and dispositive decisions regarding an entity's securities are made by two or more individuals, and a voting and dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity's securities. Based upon the foregoing analysis, neither an individual manager of Transcend nor the Reporting Person exercises voting or dispositive control over any of the Issuer's securities, even those in which such person may hold a pecuniary interest. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 23:46 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001209191-23-038123 · doc4.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2033-06-15 F1 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 15, 2023 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:04 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseCommon Stock | 250,000 | $1.00 | $250,000.00 |
DisclosureSEC source: 0001209191-23-037292 · doc4.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 528,571 F1 · price: Reporting Person purchased 250,000 shares of Common Stock in the Issuer's public offering at a purchase price of $1.00 per share. F2 · ownership.nature: The securities are held by Valley High Limited Partnership ("Valley High"). Emily Fairbairn is the sole managing partner of Valley High and has voting and investment power over the shares held by Valley High. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 20:04 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001209191-23-020718 · doc4.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-03-21 F1 · derivative.exercise_date: The option award vests in full on December 31, 2023. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 23:12 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseWarrant to Purchase Common Stock · Derivative | 89,286 | Not disclosed Strike: $1.57 | Not disclosed |
DisclosureSEC source: 0001209191-23-005533 · doc4.xml · derivative · entry 3 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 89,286 Underlying: Common Stock · 89,286 shares Expires 2028-01-31 F1 · price: Reporting Person purchased 178,571 shares of Common Stock and accompanying warrants to purchase 89,286 shares of Common Stock in the Issuer's public offering at a combined purchase price of $1.40 per share and accompanying warrant. F2 · ownership.nature: The securities are held by Valley High Limited Partnership ("Valley High"). Emily Fairbairn is the sole managing partner of Valley High and has voting and investment power over the shares held by Valley High. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 23:12 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseCommon Stock | 178,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-005533 · doc4.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 278,571 F1 · price: Reporting Person purchased 178,571 shares of Common Stock and accompanying warrants to purchase 89,286 shares of Common Stock in the Issuer's public offering at a combined purchase price of $1.40 per share and accompanying warrant. F2 · ownership.nature: The securities are held by Valley High Limited Partnership ("Valley High"). Emily Fairbairn is the sole managing partner of Valley High and has voting and investment power over the shares held by Valley High. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:17 UTC | IN8BIO, INC. INAB · Entity 7941 | PurchaseCommon Stock | 789,473 | $1.90 | $1,499,998.70 |
DisclosureSEC source: 0001209191-22-046616 · doc4.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director · 10% owner Transcend Partners Opportunity Fund LLC · CIK 0001832019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,111,958 F1 · ownership.nature: The securities are held by Transcend Partners Opportunity Fund LLC ("Transcend"). Emily Fairbairn is the sole managing member of Transcend and has voting and investment power over the shares held by Transcend. Read SEC document |
| June 01, 2022 Filed Jun 14, 2022 23:05 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 10,500 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001209191-22-036804 · doc4.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires 2032-06-01 F1 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 01, 2022 Filed Sep 23, 2022 21:06 UTC Amendment | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 13,500 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001209191-22-051160 · doc4a.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2032-06-01 F1 · shares: The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person. F2 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date. F1 · derivative.underlying_shares: The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person. F1 · balance_after: The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 20:33 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseCommon Stock | 3,011 | $2.86 | $8,611.46 |
DisclosureSEC source: 0001209191-22-022409 · doc4.xml · nonDerivative · entry 2 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,428 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.83 to $2.90, inclusive. The reporting person undertakes to provide to Movano, Inc., any security holder of Movano, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:33 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseCommon Stock | 5,000 | $2.77 | $13,850.00 |
DisclosureSEC source: 0001209191-22-022409 · doc4.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,417 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.71 to $2.79, inclusive. The reporting person undertakes to provide to Movano, Inc., any security holder of Movano, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 14:23 UTC | Corvex, Inc. MOVE · Entity 5811 | GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001367 · doc4.xml · derivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-01-03 F1 · shares: Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: The option vests in full on the one year anniversary of the grant date. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:03 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseCommon Stock | 5,000 | $3.85 | $19,250.00 |
DisclosureSEC source: 0001209191-21-066774 · doc4.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,417 Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 22:47 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseCommon Stock | 4,000 | $3.98 | $15,920.00 |
DisclosureSEC source: 0001209191-21-065900 · doc4.xml · nonDerivative · entry 2 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,417 Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 22:47 UTC | Corvex, Inc. MOVE · Entity 5811 | PurchaseCommon Stock | 1,000 | $3.95 | $3,950.00 |
DisclosureSEC source: 0001209191-21-065900 · doc4.xml · nonDerivative · entry 1 FAIRBAIRN EMILY · CIK 0001682638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,417 Read SEC document |
| August 03, 2021 Filed Aug 3, 2021 20:51 UTC | IN8BIO, INC. INAB · Entity 7941 | ConversionSeries A Preferred Stock · Derivative | 2,930,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049368 · doc4.xml · derivative · entry 7 FAIRBAIRN EMILY · CIK 0001682638 · Director · 10% owner Transcend Partners Opportunity Fund LLC · CIK 0001832019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 3,222,485 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering. F4 · ownership.nature: The securities are held by Transcend Partners Opportunity Fund LLC ("Transcend"). Emily Fairbairn is the sole managing member of Transcend and has voting and investment power over the shares held by Transcend. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.